Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karn Wijarnpreecha

Showing results (101-110 of 314) with videos related to

Pageof 32
Sort By:
Rheumatology (Oxford, England)|September 26, 2014
Non-steroidal anti-inflammatory drugs and risk of venous thromboembolism: a systematic review and meta-analysisPatompong Ungprasert, Narat Srivali, Karn Wijarnpreecha, et al.
Seminars in Arthritis and Rheumatism|December 11, 2019
Hereditary hemochromatosis is associated with increased use of joint replacement surgery: Results of a nationwide analysisPaul T Kröner, Karl F Mareth, Karn Wijarnpreecha, et al.
Journal of Clinical Medicine|March 11, 2023
Types of Physical Activity in Nonalcoholic Fatty Liver Disease and All-Cause and Cardiovascular MortalityDonghee Kim, Karn Wijarnpreecha, Brittany B Dennis, et al.
Intestinal Research|June 11, 2026
Current burden and health care utilization of inflammatory bowel disease in the United States, 2023-2024Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, et al.
Alimentary Pharmacology & Therapeutics|August 11, 2021
Editorial: when to start carvedilol in cirrhosis-time to reconsider? Authors' replyKarn Wijarnpreecha, Fang Li, C Burcin Taner, et al.
European Journal of Gastroenterology & Hepatology|June 23, 2020
Increased rates of spinal fusion surgery in patients with hereditary hemochromatosis: a five-year propensity matched cohort analysisAlex M Kesler, Paul T Kröner, Karn Wijarnpreecha, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 30, 2026
Sex Disparity in Major Adverse Liver Outcome and Major Adverse Cardiac Event in Alcohol-Associated Liver DiseasePojsakorn Danpanichkul, Donghee Kim, Karn Wijarnpreecha, et al.
Alcohol (Fayetteville, N.Y.)|March 9, 2024
The trends and incidence of alcohol-associated hepatitis hospitalizations from 2016-2020 and the impact of the COVID-19 pandemicMegan B Ghai, Pooja Rangan, Naim Alkhouri, et al.
Clinical and Molecular Hepatology|February 13, 2025
Addressing the burden of steatotic liver disease: The role of transient elastography: Correspondence to editorial on "Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023"Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, et al.
Clinical and Molecular Hepatology|November 29, 2024
Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, et al.
Pageof 32

Showing results (101-110 of 314) with videos related to

Sort By:
Pageof 32
Rheumatology (Oxford, England)|September 26, 2014
Non-steroidal anti-inflammatory drugs and risk of venous thromboembolism: a systematic review and meta-analysisPatompong Ungprasert, Narat Srivali, Karn Wijarnpreecha, et al.
Seminars in Arthritis and Rheumatism|December 11, 2019
Hereditary hemochromatosis is associated with increased use of joint replacement surgery: Results of a nationwide analysisPaul T Kröner, Karl F Mareth, Karn Wijarnpreecha, et al.
Journal of Clinical Medicine|March 11, 2023
Types of Physical Activity in Nonalcoholic Fatty Liver Disease and All-Cause and Cardiovascular MortalityDonghee Kim, Karn Wijarnpreecha, Brittany B Dennis, et al.
Intestinal Research|June 11, 2026
Current burden and health care utilization of inflammatory bowel disease in the United States, 2023-2024Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, et al.
Alimentary Pharmacology & Therapeutics|August 11, 2021
Editorial: when to start carvedilol in cirrhosis-time to reconsider? Authors' replyKarn Wijarnpreecha, Fang Li, C Burcin Taner, et al.
European Journal of Gastroenterology & Hepatology|June 23, 2020
Increased rates of spinal fusion surgery in patients with hereditary hemochromatosis: a five-year propensity matched cohort analysisAlex M Kesler, Paul T Kröner, Karn Wijarnpreecha, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 30, 2026
Sex Disparity in Major Adverse Liver Outcome and Major Adverse Cardiac Event in Alcohol-Associated Liver DiseasePojsakorn Danpanichkul, Donghee Kim, Karn Wijarnpreecha, et al.
Alcohol (Fayetteville, N.Y.)|March 9, 2024
The trends and incidence of alcohol-associated hepatitis hospitalizations from 2016-2020 and the impact of the COVID-19 pandemicMegan B Ghai, Pooja Rangan, Naim Alkhouri, et al.
Clinical and Molecular Hepatology|February 13, 2025
Addressing the burden of steatotic liver disease: The role of transient elastography: Correspondence to editorial on "Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023"Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, et al.
Clinical and Molecular Hepatology|November 29, 2024
Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, et al.
Pageof 32